Quantcast

Latest Lipids Stories

2014-05-13 16:27:44

WOODBRIDGE, ON, May 13, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced that it has engaged Brandkarma LLC., an award winning, US-based, healthcare marketing and brand specialist with global expertise to support the Company's commercialization strategy for VASCAZEN(®). "VASCAZEN(®) represents a much-needed solution for...

2014-05-12 08:28:11

BOSTON, May 12, 2014 /PRNewswire/ -- Verde Media Group Inc. (OTC:VMGI) and its Biotech Division ("VMBD") announces that Butazyme, LLC, "BTZ" a wholly owned company of VMBD, has broken ground and commenced construction of the omega-3 project site in Asia. The joint venture with Phoenix Energy "PXE" is fully financed and involves scaling and co-developing the BTZ omega-3 technology to 20,000 liters in phase-I. BTZ has developed a proprietary microbial technology to produce high value...

2014-05-07 23:14:17

“Health And Beauty Benefits Of Fish Oil Supplements For Men And Women,” a new report on the website Vkool.com uncovers health and beauty benefits of fish oil, and some reasons to love it. Seattle, WA (PRWEB) May 07, 2014 “Health And Beauty Benefits Of Fish Oil Supplements For Men And Women,” a new report created by Hafizur on the site Vkool.com shows fish oil benefits on health, skin and hair, and detailed instructions on how to use it properly. In the first part of this report,...

2014-05-07 12:30:30

WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent Number 8,715,648 titled "Formulations Comprising Omega-3 Fatty Acids and Anti-Obesity Agent for the Reduction of Body Weight in Cardiovascular Disease Patients (CVD) and Diabetics"....

2014-05-06 16:31:55

WOODBRIDGE, ON, May 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it presented two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions held in Toronto, Ontario, Canada, May 1-3, 2014. Both posters discussed Omega-3 deficiency (OM3D)...

2014-05-05 08:27:56

SBIR Grant from the National Institutes of Neurological Diseases and Stroke Provides Funds for IND-enabling Studies of Lpathomab SAN DIEGO, May 5, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the National Institutes of Neurological Diseases and Stroke (NINDS) that it has been awarded a $1.7 million, 2.5-year grant to develop its antibody therapeutic, Lpathomab(TM), which is directed...

2014-05-01 16:31:22

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it will be presenting two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions in Toronto, Ontario, Canada, May 1-3, 2014. The first poster entitled "Correlation...

2014-05-01 16:31:16

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announces a correction to its press release issued yesterday entitled "Pivotal Therapeutics Announces 2013 Financial Results". The decrease in the loss from 2012 to 2013 of $745,342 was inadvertently overstated by $91,520. The correct decrease in loss is $653,822 and...

2014-04-30 20:24:05

WOODBRIDGE, ON, April 30, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the fiscal year ended December 31, 2013. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated. Financial Review Sales for the year ended 2013 totaled $303,530 versus...

2014-04-30 10:18:48

More research is needed to better understand the important role that dietary fats play in optimal health, said a panel of leading food and nutrition scientists Friday at an American Society for Nutrition (ASN) pre-annual meeting session. More than 130 academic and industry food and nutrition scientists and registered dietitians attended the half-day ASN Satellite Symposium: Let's Chew the Fat: Current Thinking on Dietary Fats and the Food We Eat, held from 1-5 pm at the San Diego Bayfront...


Latest Lipids Reference Libraries

Vistive Gold
2013-10-02 12:54:36

Vistive Gold, MON 87705, is a genetically engineered variety of glyphosate-resistant low-linolenic, high-oleic soybeans created by Monsanto. Vistive Gold was designed to be a replacement for hydrogenated oils and fats, which are high in trans-fatty acids. The decreased linolenic content enables Vistive Gold to have favorable traits for deep frying and increasing the shelf life of foods. The Federal Register declared on June 28, 2011 that Monsanto was petitioning the Animal and Plant...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related